CSL
Carlisle Companies Incorporated
CSL has slightly lower modeled downside risk, despite its lower overall score.
VRT
Vertiv Holdings Co
VRT has the edge over CSL overall, supported by stronger valuation and stronger fundamentals.
CSL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Stable |
CSL's revenue and profitability are currently healthy, and its cash flow and balance sheet are stable.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
CSL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $258 | -34% |
| Forward | 17x | $393 | — |
| Fair | 20x | $351 | -11% |
| Current | 22x | $393 | — |
| Expensive | 26x | $459 | +17% |
Historical ranges are pointers, not guarantees.
CSL's PE is in its expensive range at 22x. If earnings grow as analysts expect, today's price would be 17x next year's earnings, in its cheap range.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT has the edge over CSL in the historical PE scenario, which offers more potential upside but is not a forecast.
CSL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CSL, with profitability improving.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for VRT, with profitability improving.
CSL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $23.69 | +34% |
| Q3 2026 | $17.70 | -0.7% |
| Q2 2026 | $17.44 | -3.6% |
| Q1 2026 | $17.02 | -37% |
| Q4 2025 | $17.12 | -38% |
| Q3 2025 | $17.82 | -37% |
| Q2 2025 | $18.09 | -36% |
| Q1 2025 | $27.05 | +57% |
| Q4 2024 | $27.82 | +83% |
CSL's earnings per share have fallen from their peak: $17.70 over the past year, against $28.30 in mid-2024.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT has the edge over CSL on earnings, with more consistent year-over-year improvement.
CSL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +8.6% |
| Q2 2026 | $1.6B | +8.3% |
| Q1 2026 | $1.1B | -4% |
| Q4 2025 | $1.1B | +0.4% |
| Q3 2025 | $1.3B | +1% |
| Q2 2025 | $1.4B | -0.1% |
| Q1 2025 | $1.1B | -0.1% |
| Q4 2024 | $1.1B | -0.4% |
CSL's revenue is recovering but still below its 2022 peak: $1.5B last quarter, up 8.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -1.8 points |
| Q2 2026 | 22% | -0.7 points |
| Q1 2026 | 17% | +0.4 points |
| Q4 2025 | 17% | -3.1 points |
| Q3 2025 | 22% | -1.9 points |
| Q2 2025 | 23% | -2.9 points |
| Q1 2025 | 17% | -3.8 points |
| Q4 2024 | 20% | -2.5 points |
CSL's operating margin was 20% last quarter, down 1.8 points from the same quarter a year ago.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT has the edge over CSL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT has the edge over CSL on profitability, with a higher operating margin.
CSL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $277.3M | -30% |
| Q2 2026 | $200.1M | -23% |
| Q1 2026 | -$73M | -$45.8M |
| Q4 2025 | $346.1M | +3.6% |
| Q3 2025 | $393.4M | +34% |
| Q2 2025 | $258.3M | +63% |
| Q1 2025 | -$27.2M | -121% |
| Q4 2024 | $334M | -5.4% |
CSL still generates free cash flow, though less than at its 2023 peak: $751M over the past year.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT has the edge over CSL on cash flow, with more consistent year-over-year improvement.
CSL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.2% | -900K shares |
| 1 year | -7.7% | -3.3M shares |
| 3 years | -21% | -10.5M shares |
| 5 years | -25% | -13.4M shares |
| Available history | -31% | -17.9M shares |
CSL has the edge over VRT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $350M |
| Q2 2026 | $250M |
| Q1 2026 | $250M |
| Q4 2025 | $300M |
| Q3 2025 | $300M |
| Q2 2025 | $300M |
| Q1 2025 | $400M |
| Q4 2024 | $419.8M |
CSL spent $1.1B buying back its own shares over the past year, down 19% from the year before.
VRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -64.9K shares |
| 1 year | +0.4% | +1.8M shares |
| 3 years | +1.1% | +4.4M shares |
| 5 years | +10% | +36M shares |
| Available history | +63% | +152M shares |
VRT has 393M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $599.9M |
CSL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.9x | Healthy |
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 1.8x | Healthy |
| Q4 2025 | 1.5x | Healthy |
| Q3 2025 | 1.5x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 0.9x | Very low |
CSL's net debt is about 1.9 years of its operating earnings (EBITDA), up from 1.4 years a year ago.
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has the edge over CSL on leverage, with a lower net debt burden relative to earnings.
CSL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.2 | Neutral |
| Stochastic | 76.1 | Neutral |
CSL's weekly RSI is 61 (neutral) and its Stochastic is 76 (neutral).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
CSL PE vs Industrials Sector
| Metric | CSL | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 24x | 7.7% below |
| PE % | 67 | 58 | 9 pts above |
CSL has the edge over VRT on valuation relative to its sector.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.
CSL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $350.0 | 12% above |
| 20 week MA | $351.1 | 12% above |
| 50 week MA | $352.1 | 11% above |
| 100 week MA | $357.0 | 10% above |
| 200 week MA | $341.9 | 15% above |
CSL has the edge over VRT on trend strength, trading above more of its moving averages.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 70% above its 200-week average.
CSL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $163.0 | $157.4 | -3.5% |
| 2021 | $157.4 | $240.8 | +53% |
| 2022 | $240.8 | $237.9 | -1.2% |
| 2023 | $237.9 | $312.4 | +31% |
| 2024 | $312.4 | $372.0 | +19% |
| 2025 | $372.0 | $330.3 | -11% |
| 2026 YTD | $330.3 | $392.6 | +19% |
CSL has finished lower in three of the last six years. It's up 19% so far in 2026.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT has the edge over CSL on returns for 2026, with the stronger performance.